Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 31,640 | 20,974 | 26,586 | 20,482 | 11,041 |
| Operating Income | -31,640 | -20,974 | -26,586 | -20,482 | -11,041 |
| Interest Expense | 0 | 0 | 0 | 0 | 376 |
| Other Income | -503 | 225 | -74 | -128 | 221 |
| Pre-tax Income | -32,143 | -20,749 | -26,660 | -20,610 | -11,196 |
| Income Tax | -367 | 40 | 48 | -59 | 100 |
| Net Income Continuous | -31,776 | -20,789 | -26,708 | -20,551 | -11,296 |
| Net Income | $-31,776 | $-20,789 | $-26,708 | $-20,551 | $-11,296 |
| EPS Basic Total Ops | -0.32 | -0.25 | -0.38 | -0.36 | -0.28 |
| EPS Basic Continuous Ops | -0.32 | -0.25 | -0.38 | -0.37 | -0.28 |
| EPS Diluted Total Ops | -0.32 | -0.25 | -0.38 | -0.36 | -0.28 |
| EPS Diluted Continuous Ops | -0.32 | -0.25 | -0.38 | -0.37 | -0.28 |
| EBITDA(a) | $-31,621 | $-20,960 | $-26,576 | $-20,476 | $-11,036 |